The relation between plasma cysteine, plasma homocysteine and coronary atherosclerosis

被引:51
作者
van den Brandhof, WE
Haks, K
Schouten, EG
Verhoef, P
机构
[1] Univ Wageningen & Res Ctr, Div Human Nutr & Epidemiol, NL-6700 EV Wageningen, Netherlands
[2] Wageningen Ctr Food Sci, NL-6700 AN Wageningen, Netherlands
关键词
cysteine; coronary atherosclerosis; homocysteine; risk factor;
D O I
10.1016/S0021-9150(00)00724-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Several studies have reported that elevated plasma levels of total homocysteine (tHcy) are related to an increased risk of cardiovascular disease. Only a few studies have looked at the effect of cysteine, another amino thiol, on cardiovascular disease risk. Therefore, in the present case-control study we compared plasma total cysteine (tCys) levels and plasma tHcy levels among subjects with severe coronary atherosclerosis (cases, n = 131), subjects without severe coronary atherosclerosis (coronary controls, n = 88) and healthy subjects (population-based controls, n = 101). Cases were defined as those having 90% occlusion in one and greater than or equal to 40% occlusion in a second coronary artery, while coronary controls had a maximum of 50% occlusion in only one coronary artery. Both males and females, aged 26-64 years were studied. We have previously reported that plasma tHcy is an independent risk factor for coronary atherosclerosis in this study population. In the present analysis, we found that cases had statistically significant higher mean plasma tCys levels than coronary controls and population-based controls (295.8 +/- 40.2, 279.0 +/- 35,5 and 282.6 +/- 32.4 mu mol/l, respectively). The odds ratio (OR) of coronary atherosclerosis for the upper tertile of tcys compared with the bottom tertile was 2.5 (95% confidence interval (CI), 1.4-4.3). However, the association between tCys and coronary atherosclerosis was confounded to a great extent by risk factors (OR, 1.0; 95% Cl, 0.5-2.0). The multivariate adjusted OR of coronary atherosclerosis per 1 S.D. increase in plasma tCys was 1.0 (95% CI, 0.8-1.3). The corresponding OR per I S.D. increase in plasma tHcy was 1.4 (95% Cl, 1.1-1.8). We conclude that plasma tCys, unlike plasma tHcy, is not an independent risk factor for atherosclerosis. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:403 / 409
页数:7
相关论文
共 27 条
[1]   PLASMA SULFHYDRYL-CONTAINING AMINO-ACIDS IN PATIENTS WITH CEREBRAL INFARCTION AND IN HYPERTENSIVE SUBJECTS [J].
ARAKI, A ;
SAKO, Y ;
FUKUSHIMA, Y ;
MATSUMOTO, M ;
ASADA, T ;
KITA, T .
ATHEROSCLEROSIS, 1989, 79 (2-3) :139-146
[2]   LIPID-PEROXIDATION IN HOMOCYSTEINAEMIA [J].
BLOM, HJ ;
ENGELEN, DPE ;
BOERS, GHJ ;
STADHOUDERS, AM ;
SENGERS, RCA ;
DEABREU, R ;
TEPOELEPOTHOFF, MTWB ;
TRIJBELS, JMF .
JOURNAL OF INHERITED METABOLIC DISEASE, 1992, 15 (03) :419-422
[3]   LIPID-PEROXIDATION AND SUSCEPTIBILITY OF LOW-DENSITY-LIPOPROTEIN TO IN-VITRO OXIDATION IN HYPERHOMOCYSTEINAEMIA [J].
BLOM, HJ ;
KLEINVELD, HA ;
BOERS, GHJ ;
DEMACKER, PNM ;
HAKLEMMERS, HLM ;
POELEPOTHOFF, MTWBT ;
TRIJBELS, JMF .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1995, 25 (03) :149-154
[4]   A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES [J].
BOUSHEY, CJ ;
BERESFORD, SAA ;
OMENN, GS ;
MOTULSKY, AG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13) :1049-1057
[5]  
Danesh J, 1998, J Cardiovasc Risk, V5, P229, DOI 10.1097/00043798-199808000-00004
[6]   Homocysteine enhances neutrophil-endothelial interactions in both cultured human cells and rats in vivo [J].
Dudman, NPB ;
Temple, SE ;
Guo, XW ;
Fu, WY ;
Perry, MA .
CIRCULATION RESEARCH, 1999, 84 (04) :409-416
[7]   HUMAN ARTERIAL ENDOTHELIAL-CELL DETACHMENT INVITRO - ITS PROMOTION BY HOMOCYSTEINE AND CYSTEINE [J].
DUDMAN, NPB ;
HICKS, C ;
WANG, J ;
WILCKEN, DEL .
ATHEROSCLEROSIS, 1991, 91 (1-2) :77-83
[8]   CIRCULATING LIPID HYDROPEROXIDE LEVELS IN HUMAN HYPERHOMOCYSTEINEMIA - RELEVANCE TO DEVELOPMENT OF ARTERIOSCLEROSIS [J].
DUDMAN, NPB ;
WILCKEN, DEL ;
STOCKER, R .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (04) :512-516
[9]   An alternative view of homocysteine [J].
Dudman, NPB .
LANCET, 1999, 354 (9195) :2072-2074
[10]  
El-Khairy L, 1999, AM J CLIN NUTR, V70, P1016